<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03934437</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00195120</org_study_id>
    <secondary_id>11244</secondary_id>
    <nct_id>NCT03934437</nct_id>
  </id_info>
  <brief_title>Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)</brief_title>
  <official_title>Leveraging mHealth and Peers to Engage African-Americans and Latinxs in HIV Care (LEAN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pragmatic randomized controlled study comparing existing linkage to care and&#xD;
      retention (LTCR) services to an mHealth-enhanced linkage to care and retention (mLTCR)&#xD;
      protocol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Baltimore's HIV prevalence rate (586/100,000) is among the top 5 in metropolitan areas in the&#xD;
      US, and disparities are profound. African Americans have an HIV prevalence that is 5 times&#xD;
      higher than among whites, and account for 78% of all HIV cases. Latinxs also have a higher&#xD;
      prevalence of HIV than whites and are at the highest risk for late HIV diagnosis among all&#xD;
      racial/ethnic groups. In addition, HIV viral load suppression, which is the best predictor of&#xD;
      long-term survival among HIV-infected patients, is substantially lower among minority&#xD;
      populations in Baltimore.&#xD;
&#xD;
      The overall goal of this proposal is to evaluate whether mHealth-enhanced Linkage to Care and&#xD;
      Retention (mLTCR) can improve HIV outcomes among HIV-infected African Americans and Latinos&#xD;
      compared to standard Linkage to Care and Retention (LTCR) programs. The mHealth-enhancement&#xD;
      consists of two smartphone applications (app), one for patients and one for patient&#xD;
      supporters (e.g. linkage officers, patient navigators, nurses, etc.), to help facilitate&#xD;
      communication. Communication will focus on issues related to HIV care (e.g. appointment&#xD;
      scheduling, transportation), as well as patient-directed requests. Using HIV surveillance&#xD;
      data (e.g. unsuppressed HIV viral load), patient supporters will be automatically alerted if&#xD;
      a patient has a high viral load and prompted to contact the patient. In addition to&#xD;
      appointment reminders, patients will receive positive reinforcement behavioral text messages.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion with HIV Viral Load Suppression (copies/cc)</measure>
    <time_frame>12 months</time_frame>
    <description>Viral Suppression defined as a viral load &lt; 200 copies/cc</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion Retained in Care</measure>
    <time_frame>12 months</time_frame>
    <description>Retained in care based upon viral load, CD4, OR clinic visit reported in enhanced HIV/AIDS Reporting System (eHARS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>HIV/AIDS</condition>
  <arm_group>
    <arm_group_label>mLTCR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The mLTCR intervention consists of two smartphone applications (app), one for patients and one for patient supporters, to help facilitate communication.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LTC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Existing linkage to care and retention (LTCR) services which are standard-of-care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mLTCR</intervention_name>
    <description>mHealth-enhanced Linkage to Care and Retention</description>
    <arm_group_label>mLTCR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>LTCR</intervention_name>
    <description>Linkage and Retention Services (Standard-of-Care)</description>
    <arm_group_label>LTC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â‰¥ 18 years of age&#xD;
&#xD;
          -  Ability to provide consent&#xD;
&#xD;
          -  Identified by BCHD Linkage protocol to be a new HIV diagnosis or HIV-infected and &quot;out&#xD;
             of care&quot;&#xD;
&#xD;
          -  Identified by participating clinics as needing patient support services&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not able to provide consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathleen W Page</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathleen Page, MD</last_name>
    <phone>(410) 614-1814</phone>
    <email>kpage2@jhmi.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Baltimore City Health Department</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Page</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 29, 2019</study_first_submitted>
  <study_first_submitted_qc>April 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2019</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Requests for data sharing should be made to the PI.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Within 1 year after study recruitment has begun.</ipd_time_frame>
    <ipd_access_criteria>All reasonable requests will be considered.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

